20487 ⎘
Medicinal preparations containing organic active ingredients; Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
Compositions, formulations and methods of treating preeclampsia-type disorders of pregnancy
#602SOFT ELASTIC CAPSULES CONTAINING TABLETS AND LIQUID OR SEMISOLID FILLS AND METHODS FOR THEIR MANUFACTURE
#603Aqueous drug delivery system
#604PHARMACEUTICAL COMPOSITIONS CONTAINING DIMETHYL FUMARATE
#605DRUG-ELUTING MEDICAL DEVICES
#606Combination of regorafenib and acetylsalicylic acid for treating cancer
#607METHOD OF TREATING CARDIOVASCULAR EVENTS USING COLCHICINE CONCURRENTLY WITH AN ANTITHROMBOTIC DRUG
#608Method of treating cardiovascular events using colchicine concurrently with an antiplatelet agent
#609Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk
#610Combined F2-isoprostane and myleoperoxidase detection, a risk indicator for cardiovascular disease
#611PNEUMATIC WRAP COMPRESSION TREATMENTS FOR VENOUS CONDITIONS
#612Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle
#613Sequential administration of partitioned absorption aspirin or active aspirin derivative and COX-2 inhibitor
#614Method for a Wellbeing Therapy Program
#615Compositions and methods for the treatment of restless leg syndrome and fibromyalgia
#616Delayed release drug formulation
#617Dry-coated tablet
#618Delayed release drug formulation
#619Immediate release abuse-deterrent granulated dosage forms
#620Immediate release abuse-deterrent granulated dosage forms
#621Method and composition for preventing stem cell disruption and aggregation
#622Materials and methods for treatment and diagnosis of disorders associated with oxidative stress
#623Methods and compositions for treating and preventing signs or symptoms of eye disease
#624Pharmaceutical compositions for the delivery of substantially water-insoluble drugs
#625CONTROLLED DOSING OF CLOPIDOGREL WITH GASTRIC ACID INHIBITION THERAPIES
#626ASPIRIN FORMULATION FOR INCREASED EFFICACY
#627Self-assembling bis-urea compounds for drug delivery
#628Preparation and use of bicyclic himbacine derivatives as PAR-1 receptor antagonists
#629PHASED DOSING OF CLOPIDOGREL
#630TREATMENT OF SKIN DISEASE
#631Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity
#632PHARMACEUTICAL FORMULATION FOR REDUCING BLADDER SPASMS AND METHOD OF USE THEREOF
#633Compounds and methods for the treatment of vascular disease
#634Benzamides and related inhibitors of factor Xa
#635Multi-purpose anti-itch treatment
#636Compositions and methods for delivery of omeprazole plus acetylsalicylic acid
#637ABSORBABLE ENCAPSULATED CALCIUM IN HYPROMELLOSE CAPSULE
#638Enteric soft capsules
#639BIOMARKERS OF KAWASAKI DISEASE
#640ADJUVANT TO THROMBOLYTIC THERAPY FOR THE TREATMENT OF FROSTBITE
#641ORALLY DISPERSIBLE DRUG FORMULATIONS
#642External Preparation Containing NSAIDS And Method For Producing The External Preparation
#643Dry coated tablet
#644Stable formulations of antiplatelet agents, omega-3 fatty acids and amylose in soft gelatin capsules
#645Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydromorphone, prodrugs, methods of making and use thereof
#646METHODS FOR TREATING CARDIOVASCULAR DISORDER
#647Clear solid sticks with solubilized pharmaceutical agents
#648ANTI-INFLAMMATORY AND ANTIDIABETIC AGENTS
#649NSAIDs-induced gastrointestinal mucosal disorder alleviator and manufacturing method thereof
#650Dry powder formulations and methods of use
#651INTRAVENOUS FORMULATION WITH WATER-SOLUBLE COCRYSTALS OF ACETYLSALICYLIC ACID AND THEANINE
#652Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine
#653Pharmaceutical salts and polymorphs of a factor Xa inhibitor
#654Pharmaceutical formulation for reducing frequency of urination and method of use thereof
#655Use of analgesic potentiating compounds to potentiate the analgesic properties of an analgesic compound
#656METHOD OF DETERMINING PRIOR HISTORY OF ISCHEMIC STROKE FOR CURRENT RISK EVALUATION AND THERAPY GUIDANCE
#657Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
#658Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
#659Chewable enteric coated aspirin tablets
#660Soft gelatin capsules
#661INTRAVENOUS FORMULATION WITH WATER-SOLUBLE COCRYSTALS OF ACETYLSALICYLIC ACID AND THEANINE
#662Fast-setting alkoxysilane spray foams
#663Composite formulation comprising a tablet encapsulated in a hard capsule
#664COMBINATION TABLET WITH CHEWABLE OUTER LAYER
#665Vaccine composition
#666TREATMENT OF INFLAMMATORY DISEASE OR DISORDER AND COMPOSITIONS THEREFOR
#667Isometheptene isomer
#668MIXTURE FOR TRANSDERMAL DELIVERY OF LOW AND HIGH MOLECULAR WEIGHT COMPOUNDS
#669Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine
#670PHARMACEUTICAL FORMULATION FOR REDUCING FREQUENCY OF URINATION AND METHOD OF USE THEREOF
#671Dry powder inhaler and methods of use
#672Dry powder inhaler and methods of use
#673COMPOSITIONS FOR AMELIORATING SYSTEMIC INFLAMMATION AND METHODS FOR MAKING AND USING THEM
#674Multiple-component solid phases containing at least one active pharmaceutical ingredient
#675Solid solution compositions and use in chronic inflammation
#676Solid Solution Compositions and Use in Severe Pain
#677Compositions comprising anti-CD38 antibodies and lenalidomide
#678EXTENDED-RELEASE FORMULATION FOR REDUCING THE FREQUENCY OF URINATION AND METHOD OF USE THEREOF
#679Methods and Compositions for Improved Tissue Regeneration by Suppression of Interferon-Gamma and Tumor Necrosis Factor-Alpha
#680Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine
#681Ticagrelor co-crystal
#682SOLID PHARMACEUTICAL DOSAGE FORM OF TICAGRELOR
#683Compositions and methods of preventing or ameliorating abnormal thrombus formation and cardiovascular disease
#684Solid Solution Compositions and Use in Cardiovascular Disease
#685pH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same
#686pH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same
#687Compositions and methods for the treatment of pain
#688Use of stabilized granules containing glyceryl trinitrate for arteriogenesis
#689ANALGESIC COMPOSITION AND METHOD OF MAKING THE SAME
#690Delayed release drug formulation
#691PRAMIPEXOLE TRANSDERMAL DELIVERY FOR SEVERE HEADACHES
#692COMBINED FORMULATION WITH IMPROVED STABILITY
#693VON WILLEBRAND FACTOR SPECIFIC BINDERS AND METHODS OF USE THEREFOR
#694Method of Ameliorating Clotting Pathologies and Related Materials and Methods
#695POLYMORPHISM IN THE APO(A) GENE PREDICT RESPONSIVENESS TO ACETYLSALICYLIC ACID TREATMENT
#696Methods for the treatment or prophylaxis of thrombosis or embolism
#697Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA
#698Compositions and methods useful for ameliorating age related maladies
#699Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine
#700STABLE COMPOSITION COMPRISING CHOLESTEROL-LOWERING AGENTS, ANTIHYPERTENSIVE AGENTS AND ANTIPLATLET AGENTS
#701TWO SPEED MONOLITHIC SYSTEM FOR CONTROLLED RELEASE OF DRUGS
#702Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-di methyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a salicylic acid component
#703Protection of renal tissues from ischemia through inhibition of the proliferative kinases CDK4 and CDK6
#704Pharmaceutical Compositions Containing Dimethyl Fumarate
#705Pharmaceutical formulation for reducing frequency of urination and method of use thereof
#706Soft Elastic Capsules Containing Tablets and Liquid or Semisolid Fills and Methods for Their Manufacture
#707Compositions and methods for the prevention and treatment of diseases or conditions associated with oxidative stress, inflammation, and metabolic dysregulation
#708Long acting dual release product containing carbinoxamine and pseudoephedrine
#709MAGNETIC NANODRUG FOR TREATING THROMBOSIS
#710Method of treating ear infections
#711PHARMACEUTICAL COMPOSITE FORMULATION COMPRISING HMG-COA REDUCTASE INHIBITOR AND ASPIRIN
#712ORALLY DISINTEGRATING TABLET
#713Pharmaceutical Forms and Methods for Designing the Same
#714Delayed-release formulation for reducing the frequency of urination and method of use thereof
#715Extended-release formulation for reducing the frequency of urination and method of use thereof
#716Formulation for the prevention of cardiovascular disease
#717PROCESS FOR INHIBITION OF CEREBRAL DAMAGE ASSOCIATED WITH ISCHEMIA BY ANTHOCYANINS AND ANTHOCYANIDINS
#718Extended-release formulation for reducing the frequency of urination and method of use thereof
#719Use of composition in preparing drugs for secondary prevention of coronary heart disease
#720Method for treating and diagnosing cancer by using cell-derived microvesicles
#721Combination tablet with chewable outer layer
#722Treatment of Respiratory Disorders
#723Solid dosage form that promotes reliable oral, esophageal and GI transit
#724Anti-flush compositions
#725AMINOTHIAZOLE DERIVATIVES AS HUMAN STEAROYL-COA DESATURASE INHIBITORS
#726METHODS AND COMPOSITIONS FOR TREATING, REVERSING, INHIBITING OR PREVENTING RESISTANCE TO ANTIPLATELET THERAPY
#727pH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same
#728Active agents and their oligomers and polymers
#729DENTINAL DRUG DELIVERY COMPOSITION AND SCREENING METHOD
#730PHARMACEUTICAL COMPOSITIONS OF NSAID AND ACID INHIBITOR
#731NOVEL PHARMACEUTICAL SALTS AND POLYMORPHS OF A FACTOR XA INHIBITOR
#732Uses of Noscapine and Derivatives in Subjects Diagnosed with FAP
#733Di-aspirin derivatives
#734Formulations from derivatives of curcumin, paclitaxel, and aspirin
#735Solid pharmaceutical dosage form of ticagrelor
#736Pain relieving composition
#737INTRAVENOUS FORMULATION WITH WATER-SOLUBLE COCRYSTALS OF ACETYLSALICYLIC ACID AND THEANINE
#738Strip for the delivery of oral care compositions
#739Pharmaceutical composition
#740Analgesic composition and method of making the same
#741COMPLEX FORMULATION COMPRISING ASPIRIN COATED WITH BARRIER CONTAINING HYDROPHOBIC ADDITIVE, AND HMG-COA REDUCTASE INHIBITOR
#742Extended-release formulation for reducing the frequency of urination and method of use thereof
#743Delayed-release formulation for reducing the frequency of urination and method of use thereof
#744METHOD FOR MANUFACTURING ACID PELLETS
#745THERAPEUTIC USES OF NICOTINE
#746PREPARATION OF AN ACETYL SALICYLIC ACID/GLUTAMIC ACID COMPLEX FOR ORAL ADMINISTRATION
#747USE OF IRBESARTAN FOR THE PREPARATION OF A MEDICAMENT FOR THE PREVENTION OF HOSPITALIZATION FOR HEART FAILURE
#748EXTENDED-RELEASE FORMULATION FOR REDUCING THE FREQUENCY OF URINATION AND METHOD OF USE THEREOF
#749DELAYED-RELEASE FORMULATION FOR REDUCING THE FREQUENCY OF URINATION AND METHOD OF USE THEREOF
#750Iontophoretic system for transdermal delivery of active agents for therapeutic and medicinal purposes
#751Pain relieving composition
#752Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine
#753Medicaments for inhibiting thrombus formation
#754Compositions for Reducing the Incidence of Drug Induced Arrhythmia
#755METHOD FOR TREATING A PATIENT IN NEED OF ASPIRIN THERAPY
#756Extended-release formulation for reducing the frequency of urination and method of use thereof
#757Delayed release formulation for reducing the frequency of urination and method of use thereof
#758SUGAR-FREE CHEWABLE SUPPLEMENT
#759Xylitol containing comestible product
#760Disintegrating particle composition and orally rapidly disintegrating tablet
#761DELAYED RELEASE FORMULATION FOR REDUCING THE FREQUENCY OF URINATION AND METHOD OF USE THEREOF
#762Solid dosage form that promotes reliable oral, esophageal and GI transit
#763External Preparation Containing NSAIDs And Method For Producing The External Preparation
#764EXTENDED-RELEASE FORMULATION FOR REDUCING THE FREQUENCY OF URINATION AND METHOD OF USE THEREOF
#765Aqueous drug delivery system
#766Vasoprotective and cardioprotective antidiabetic therapy
#767METHODS AND COMPOSITIONS RELATED TO SYNERGISTIC RESPONSES TO ONCOGENIC MUTATIONS
#768COMPOSITIONS, FORMULATIONS AND METHODS OF TREATING PREECLAMPSIA-TYPE DISORDERS OF PREGNANCY
#769Acetylsalicylic acid salts
#770Benzamides and related inhibitors of factor XA
#771Treatment for dyslipidemia
#772Niacin mimetics, and methods of use thereof
#773Skin treatment compositions
#774Materials and methods for treatment and diagnosis of disorders associated with oxidative stress
#775Compositions, methods, and systems relating to controlled crystallization and/or nucleation of molecular species
#776Protective coatings for acidic active ingredients
#777PREPARATION OF AN ACETYL SALICYLIC ACID/GLUTAMIC ACID COMPLEX FOR ORAL ADMINISTRATION
#778Methods for the treatment or prophylaxis of thrombosis or embolism
#779Stable soft capsule dosage form for acetylsalicylic acid
#780FIXED DOSE DRUG COMBINATION FORMULATIONS
#781LIQUID-FILLED CHEWABLE SUPPLEMENT
#782Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle
#783ANTIPLATELET AGENT AND METHODS OF USING THE SAME
#784Use of salt of an acetylsalicylic acid for the treatment of viral infections
#785BIOMARKERS FOR DIAGNOSIS OF TRANSIENT ISCHEMIC ATTACKS
#786COMBINATION PREPARATION COMPRISING INHIBITOR OF HMG-COA REDUCTASE AND ASPIRIN AND METHOD FOR MANUFACTURING THE SAME
#787ACETYLATED AMINO ACIDS AS ANTI-PLATELET AGENTS, NUTRITIONAL AND VITAMIN SUPPLEMENTS
#788NSAIDS-INDUCED GASTROINTESTINAL MUCOSAL DISORDER ALLEVIATOR AND MANUFACTURING METHOD THEREOF
#789Chewable, swallowable and effervescent solid dosage form for oral delivery of pharmaceutical actives
#790PHARMACEUTICAL FORMULATIONS COMPRISING NSAID AND PROTON PUMP INHIBITOR DRUGS
#791MYELOPEROXIDASE, A RISK INDICATOR FOR CARDIOVASCULAR DISEASE
#792N-acyl anthranilic acid derivative or salt thereof
#793Acetylated amino acids as anti-platelet agents, nutritional and vitamin supplements
#794Method for treating a mammal by administration of a compound having the ability to release CO
#795DRUG DELIVERY COMPOSITIONS AND METHODS USING NANOFIBER WEBS
#796POLYMORPHISM IN THE APO(A) GENE PREDICT RESPONSIVENESS TO ACETYLSALICYLIC ACID TREATMENT
#797Drug Delivery Using Fine Fiber Encapsulation
#798Drug delivery composition
#799VON WILLEBRAND FACTOR SPECIFIC BINDERS AND METHODS OF USE THEREFOR
#800Combined F2-isoprostane and myeloperoxidase detection, a risk indicator for cardiovascular disease
#801THERAPEUTIC AGENT FOR ANCA-RELATED VASCULITIS
#802DISSOLVABLE PHARMACEUTICAL IMPLANT
#803METHOD OF TREATING ILEUS BY PHARMACOLOGICAL ACTIVATION OF CHOLINERGIC RECEPTORS
#804Stable Orally Disintegrating Tablets Having Low Superdisintegrant
#805Method of inhibiting platelet aggregation and clot formation
#806Method for making and using a topical dermatological solution
#807Capsule for the prevention of cardiovascular diseases
#808HEAT RESISTANT DELIVERY SYSTEM
#809Methods of making compositions comprising lecithin oils and NSAIDS for protecting the gastrointestinal tract and providing enhanced therapeutic activity
#810Methods of treating inflammation with compositions comprising lecithin oils and NSAIDS for protecting the gastrointestinal tract and providing enhanced therapeutic activity
#811Persistent and fast acting antiseptics and disinfectants based on calcium fluoride
#812COMPOSITE PREPARATION
#813Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity
#814Combination of Oral Medicaments Bonded by a Wrapping
#815Use of analgesic potentiating compounds to potentiate the analgesic properties of an analgesic compound
#816Method for Treating a Patient in Need of Aspirin Therapy
#817Pharmaceutical Co-Crystal Compositions
#818ACTIVE AGENTS AND THEIR OLIGOMERS AND POLYMERS
#819Benzamides and related inhibitors of factor Xa
#820Compositions and methods for reducing hepatotoxicity associated with drug administration
#821ANTI-PYRETIC VASODILATORS
#822Compounds and methods for the treatment of vascular disease
#823USE OF INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE TO SYNERGIZE ACTIVITY OF COX AND 5-LOX INHIBITORS
#824Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine
#825Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases
#826Portable powder delivery system and method
#827Method for delivering a combination of resveratrol and aspirin for use in treatment and prevention of vascular disease
#828Method for oral mucosal absorption of acetyl salycylic acid
#829Compositions and Methods for Treatment and Prevention of Cardiovascular Disease
#830Treating alzheimer's disease and osteoporosis and reducing aging
#831Combination Therapy for Neuroprotection
#832Therapeutic treatment
#833Iontophoretic system for transdermal delivery of active agents for therapeutic and medicinal purposes
#834USE OF ANTIBODIES AGAINST THE CD52 ANTIGEN FOR THE TREATMENT OF NEUROLOGICAL DISORDERS, PARTICULARLY TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY AND ALZHEIMER'S DISEASE
#835OIL-BASED NSAID COMPOSITIONS AND METHODS FOR MAKING AND USING SAME
#836Formulation of aspirin that is stable and showing minimal hydrolysis for parenteral administration for the treatment of cardiovascular and other disease states
#8377,8,10,10A-TETRAHYDRO-6H-BENZO[C]CHROMEN-9(6AH)-ONE MODULATORS OF CANNABINOID RECEPTORS
#838Combination tablet with chewable outer layer
#839Anti-bacterial plant compositions
#840COMBINATION THERAPY OF ARTHRITIS WITH TRANILAST
#841Aminothiazole derivatives as human stearoyl-CoA desaturase inhibitors
#842ANALGESIC COMPOSITION OF TOPICALLY APPLIED NONSTEROIDAL ANTIINFLAMMATORY DRUGS AND OPIOIDS
#843Magnetic microsphere and method of forming a microsphere
#844COMBINATION THERAPY OF SUBSTITUTED OXAZOLIDINONES
#845METHODS AND COMPOSITIONS FOR TREATING GASTROINTENSTIAL DISORDERS
#846DIPYRIDAMOLE AND ACETYLSALICYLIC ACID FORMULATIONS AND PROCESS FOR PREPARING SAME
#847TREATMENT AND PREVENTION OF CARDIOVASCULAR EVENTS
#848Methods of using crystalline forms of a salt of a factor Xa inhibitor
#849Use of ribose in first response to acute myocardial infarction
#850Pharmaceutical composition combining tenatoprazole and an anti-inflammatory agent
#851NIACIN AND NSAID COMBINATION THERAPY
#852CONCURRENT DRUGS
#853METHOD TO IDENTIFY AND TREAT SUBJECTS RESISTANT TO ACETYL SALICYLIC ACID
#854CHEWABLE PHARYNGEAL INFLAMMATION SYMPTOM RELIEF COMPOSITION
#855Methods and compositions for treating platelet-related disorders
#856Long Chain Polyunsaturated Fatty Acids and Methods of Making and Using the Same
#857COMBINATION OF A TRIPTAN AND AN NSAID
#858Compositions and methods for reducing hepatotoxicity associated with drug administration and treating non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and associated cirrhosis
#859Stable active compound complex of salts of o-acetylsalicylic acid with basic amino acids and glycine
#860Water-soluble films comprising low-viscosity alginates
#861Oral dosage forms including an antiplatelet agent and an enterically coated acid inhibitor
#862Apiary veterinary composition
#863Method for the reduction of dangerous blood sugar levels
#864Modulation of Peripheral Clocks in Adipose Tissue
#865USE OF NICOTINE, ANALOGUES, THEREOF, PRECURSORS THEREOF OR DERIVATIVES THEROF IN THE TREATMENT OF VARIOUS PATHOLOGICAL PROCESSES CAPABLE OF IMPROVEMENT WITH a-MSH ADMINISTERED IN PROPHYLACTIC OR THERAPEUTIC FORM
#866Pharmaceutical Capsules Comprising Extended Release Dipyridamole Pellets
#867Oral composition comprising a polyunsaturated fatty acid and salicylic acid for obtaining an antiinflammatory effect in skin
#868GRANULATED PARTICLES, TABLETS AND METHOD FOR PRODUCING GRANULATED PARTICLES
#869Particles in a capsule
#870Benzamides and related inhibitors of factor Xa
#871Use of Sodium Channel Blocking Compounds and Aspirin in Manufacturing Drugs for Producing Analgesia Synergistically in Mammals
#872Composition and Method for Treatment and Prevention of Atherosclerosis
#873Compositions comprising lipophilic active compounds and method for their preparation
#874Long acting dual release product containing carbinoxamine and pseudoephedrine
#875Methods and compositions for inhibition of angiogenesis
#876COMPOSITIONS FOR INHIBITING AND PREVENTING VASCULAR OCCLUSION CONTAINING NUTRITIONAL SUPPLEMENTS
#877DELAYING THE AGEING PROCESS AND DISORDERS CAUSED BY AGEING
#878Use of Salicylate as an Antidote for Paraquat Intoxications in Mammals
#879Treatment of Depression
#880Polymorphism in the Apo(a) gene predict responsiveness to acetylsalicylic acid treatment
#881USE OF INHIBITORS OF THE RENIN-ANGIOTENSIN SYSTEM IN THE PREVENTION OF CARDIOVASCULAR EVENTS
#882Combination Therapy for Treating Cyclooxygenase-2 Mediated Diseases or Conditions in Patients at Risk of Thrombotic Cardiovascular Events
#883Fast-dissolving/disintegrating film preparation having high proportion of active
#884Soft gelatin capsules
#885Novel Indications for Transforming Growth Factor-Beta Regulators
#886Composition for treating metabolic syndrome
#887Mixture for Transdermal Delivery of Low and High Molecular Weight Compounds
#888Pharmaceutical Formulation Comprising Low Crystallinity Cellulose
#889Methods and compositions for treating platelet-related disorders
#890Method of treatment with coadministration of aspirin and prasugrel
#891ANTIALLERGIC AGENTS
#892Myeloperoxidase, a risk indicator for cardiovascular disease
#893Analgesic/Antipyretic Compositions for Enhanced Absorption
#894Compositions and methods useful for treatment of respiratory illness
#895Compositions and kits useful for treatment of respiratory illness
#896Compositions and methods useful for treatment of respiratory illness
#897Oral dosage forms including an antiplatelet agent and an acid inhibitor
#898Pharmaceutical composition containing sympathomimetic amine salt and co-distillable additive
#899Disease modifying anti-arthritic activity of 2-methoxyestradiol
#900NUTRITIONAL SUPPLEMENT FOR PREGNANT FEMALES